Xuemei Zhao obtained her Ph.D. in Chemistry at Columbia University and did her postdoctoral training at Cold Spring Harbor Laboratory. Afterwards, Xuemei joined the Proteomics Department at Merck Research Laboratories. Her group was responsible for biochemical sample preparation for LC-MS based proteomics profiling in biomarker discovery and new target identification. Xuemei then moved on to focus on clinical biomarker development and implementation. Currently, Xuemei leads the immunoassay group in Translational Molecular Biomarkers to support clinical programs across all disease areas at Merck.